The Centre for Liver and Gastrointestinal Research is directed by Professor Philip Newsome (Chair of Hepatology), and is based in the state of the art JIF-funded Institute of Biomedical Research. The Centre for Liver and Gastrointestinal Research staff comprises non-clinical academics (Simon Afford, Patricia Lalor, Chris Weston, Wei Yu), three Clinician Scientists (Ye Oo, Shishir Shetty and Palak Trivedi), three Lecturers, 8 post-doctoral Research Fellows, 3 Research Associates, 8 full-time grant funded clinical Research Fellows, 6 Ph.D. students and 3 technicians. The unit has a proven track record and currently holds grants from the MRC, Wellcome Trust, BBSRC, European Commission, NIHR and Innovate UK. In addition to basic research activity in the fields of immunology/autoimmune liver disease, liver regeneration, acute and acute on chronic liver failure, fatty liver disease and (stem) cell biology. The Centre for Liver and Gastrointestinal Research has strong active links with industry which include Geron (human embryonic stem cells), Novo Nordisk (Glucagon-1 like peptide analogues), Novartis (Th17 cells), Intercept, FalkPharma, Lumena, Unilever, Sanofi and Pfizer. The Centre for Liver and Gastrointestinal Research in Birmingham hosts a NIHR Biomedical Research Centre in inflammation which has significantly facilitated our efforts to translate our findings to benefit patients in the future. This includes a programme of work spanning immune mediated liver injury, including clinical trials of stem cells and immunotherapy. Professor Newsome is the Director of the Centre.